FFS
LLY icon

Founders Financial Securities’s Eli Lilly LLY Stock Holding History

Founders Financial Securities’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.4M Buy
1,169
+33
+3% +$33.7K 0.07% 250
2026
Q1 		$1.08M Sell
1,136
-404
-26% -$410K 0.06% 275
2025
Q4 		$1.65M Buy
1,540
+532
+53% +$509K 0.1% 197
2025
Q3 		$769K Sell
1,008
-1,702
-63% -$1.27M 0.05% 286
2025
Q2 		$2.11M Buy
2,710
+13
+0.5% +$10.1K 0.16% 123
2025
Q1 		$2.37M Buy
2,697
+1,034
+62% +$860K 0.2% 105
2024
Q4 		$1.28M Buy
1,663
+99
+6% +$82K 0.12% 154
2024
Q3 		$1.39M Sell
1,564
-907
-37% -$815K 0.13% 142
2024
Q2 		$2.24M Buy
2,471
+987
+67% +$790K 0.21% 98
2024
Q1 		$1.15M Sell
1,484
-740
-33% -$527K 0.12% 148
2023
Q4 		$1.3M Buy
2,224
+1,043
+88% +$609K 0.14% 127
2023
Q3 		$634K Sell
1,181
-172
-13% -$88.6K 0.08% 184
2023
Q2 		$635K Sell
1,353
-512
-27% -$215K 0.08% 184
2023
Q1 		$640K Buy
1,865
+1,122
+151% +$378K 0.09% 174
2022
Q4 		$272K Sell
743
-46
-6% -$16.3K 0.04% 267
2022
Q3 		$255K Buy
+789
New +$250K 0.05% 254
2017
Q1 		– Sell
-5,066
Closed -$373K – 105
2016
Q4 		$373K Buy
+5,066
New +$377K 0.16% 64
2015
Q1 		– Sell
-42,719
Closed -$2.95M – 84
2014
Q4 		$2.95M Buy
42,719
+2,972
+7% +$201K 1.76% 12
2014
Q3 		$2.58M Buy
39,747
+4,227
+12% +$268K 1.66% 16
2014
Q2 		$2.21M Buy
35,520
+5,365
+18% +$320K 1.48% 15
2014
Q1 		$1.77M Buy
30,155
+5,744
+24% +$321K 1.19% 20
2013
Q4 		$1.25M Buy
+24,411
New +$1.22M 1.04% 26

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Founders Financial Securities's LLY Position: Q2 2026 in Review

Founders Financial Securities increased its Eli Lilly (LLY) stake by 2.9% in Q2 2026, buying an estimated $33.7K and bringing the position to 1,169 shares worth $1.4M. The position accounts for 0.07% of the portfolio, ranked #250.

Founders Financial Securities first reported a position in LLY in Q4 2013 and has held it in 22 quarters since. The position peaked at $2.95M in Q4 2014. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Founders Financial Securities held 1,169 shares of Eli Lilly worth $1.4M as of Q2 2026.
  • Founders Financial Securities bought 33 Eli Lilly shares in Q2 2026, an estimated $33.7K.
  • Eli Lilly made up 0.07% of Founders Financial Securities's portfolio in Q2 2026, its #250 holding.
  • Founders Financial Securities first reported a position in Eli Lilly in Q4 2013 and has held it in 22 quarters since.
  • Founders Financial Securities's Eli Lilly position peaked at $2.95M in Q4 2014.
  • 4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Founders Financial Securities's 13F filing for Q2 2026, filed 31 Jul 2026.